Paper23372829
Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential.
Mosoyan G and 10 others. PLoS One, 2013. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential. Papers, record 23372829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23372829
- Cell line
- ARM-C1 paper
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Multiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potential.
- PubMed
Connected records5
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Cell Line, Tumor | Major topic |
| Cell Transformation, Neoplastic | Major topic |
| Animals | |
| Antineoplastic Agents, Hormonal | |
| CD24 Antigen | |
| Cell Proliferation | |
| Estrogen Receptor alpha | |
| Female | |
| Gene Amplification | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Hyaluronan Receptors | |
| Mice | |
| Neoplasm Metastasis | |
| Neoplastic Stem Cells | |
| Erb-b2 Receptor Tyrosine Kinases | |
| Side-Population Cells | |
| Tamoxifen | |
| Transplantation, Heterologous | |
| Tumor Suppressor Protein p53 |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15090535 | The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15090535 | PubMed |
| 2 | 20086172 | The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. | Cancer Res | 2010 | https://conductscience.org/library/papers/20086172 | PubMed |
| 3 | 16541312 | Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines. | Breast Cancer Res Treat | 2006 | https://conductscience.org/library/papers/16541312 | PubMed |
| 4 | 20696891 | Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20696891 | PubMed |
| 5 | 10769055 | AgarCyto: a novel cell-processing method for multiple molecular diagnostic analyses of the uterine cervix. | J Histochem Cytochem | 2000 | https://conductscience.org/library/papers/10769055 | PubMed |
| 6 | 20221692 | Estrogen levels act as a rheostat on p53 levels and modulate p53-dependent responses in breast cancer cell lines. | Breast Cancer Res Treat | 2011 | https://conductscience.org/library/papers/20221692 | PubMed |
| 7 | 20593380 | p53 Pro72Arg polymorphism and prostate cancer in men of African descent. | Prostate | 2010 | https://conductscience.org/library/papers/20593380 | PubMed |
| 8 | 15254720 | Basal and luminal breast cancers: basic or luminous? (review). | Int J Oncol | 2004 | https://conductscience.org/library/papers/15254720 | PubMed |
| 9 | 18591932 | HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. | Oncogene | 2008 | https://conductscience.org/library/papers/18591932 | PubMed |
| 10 | 21454683 | Cancer susceptibility polymorphism of p53 at codon 72 affects phosphorylation and degradation of p53 protein. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21454683 | PubMed |
| 11 | 20549698 | p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines. | Int J Cancer | 2011 | https://conductscience.org/library/papers/20549698 | PubMed |
| 12 | 21115003 | TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3. | Exp Mol Pathol | 2011 | https://conductscience.org/library/papers/21115003 | PubMed |
| 13 | 20878064 | Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenografts. | Int J Oncol | 2010 | https://conductscience.org/library/papers/20878064 | PubMed |
| 14 | 20637859 | Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation. | Cell Signal | 2010 | https://conductscience.org/library/papers/20637859 | PubMed |
| 15 | 12406101 | Exploring polycythaemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detected. | Br J Haematol | 2002 | https://conductscience.org/library/papers/12406101 | PubMed |
| 16 | 19048115 | Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations. | Neoplasia | 2008 | https://conductscience.org/library/papers/19048115 | PubMed |
| 17 | 17545634 | Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents. | Cancer Res | 2007 | https://conductscience.org/library/papers/17545634 | PubMed |
| 18 | 19443566 | Cell lines as candidate reference materials for quality control of ERBB2 amplification and expression assays in breast cancer. | Clin Chem | 2009 | https://conductscience.org/library/papers/19443566 | PubMed |
| 19 | 15609317 | Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. | Int J Cancer | 2005 | https://conductscience.org/library/papers/15609317 | PubMed |
| 20 | 18245484 | Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function. | Cancer Res | 2008 | https://conductscience.org/library/papers/18245484 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42797444 | Triple-Frequency Electromagnetic Stimulation Combined with Fingolimod Reduces Breast Cancer Cell Proliferation and Metastasis-Associated Extracellular Vesicle Protein Levels. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42797444 | PubMed |
| 36088362 | Immunologically "cold" triple negative breast cancers engraft at a higher rate in patient derived xenografts. | NPJ Breast Cancer | 2022 | https://conductscience.org/library/papers/36088362 | PubMed |
| 35454796 | Oestrogen Receptor Isoforms May Represent a Therapeutic Target in Oesophageal Adenocarcinoma. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35454796 | PubMed |
| 34455715 | Identification of CCNB2 as A Potential Non-Invasive Breast Cancer Biomarker in Peripheral Blood Mononuclear Cells Using The Systems Biology Approach. | Cell J | 2021 | https://conductscience.org/library/papers/34455715 | PubMed |
| 33465556 | Opioids drive breast cancer metastasis through the δ-opioid receptor and oncogenic STAT3. | Neoplasia | 2021 | https://conductscience.org/library/papers/33465556 | PubMed |
| 31848918 | Endometrial cancer and its cell lines. | Mol Biol Rep | 2020 | https://conductscience.org/library/papers/31848918 | PubMed |
| 29187162 | Isolation and characterization of a new naturally immortalized human breast carcinoma cell line, KAIMRC1. | BMC Cancer | 2017 | https://conductscience.org/library/papers/29187162 | PubMed |
| 26115764 | Tamoxifen induces a pluripotency signature in breast cancer cells and human tumors. | Mol Oncol | 2015 | https://conductscience.org/library/papers/26115764 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23372829
GET https://conductscience.org/api/papers/v1/23372829/references?page=2